Evidence map›Paper›PMID 28450887›Full record

ArticleBiotechnology for biofuels2017

Process relevant screening of cellulolytic organisms for consolidated bioprocessing.

Elena Antonov, Ivan Schlembach, Lars Regestein, Miriam A Rosenbaum, Jochen Büchs

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Insights intoEngineering in life sciences · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Online evaluation of the metabolic activity ofJournal of biological engineering · 2018
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elena Antonov *AVT‑Biochemical Engineering, RWTH Aachen University, Forckenbeckstr. 51, 52074 Aachen, Germany.ORCID 0000-0001-5397-5782
Ivan Schlembach *Institute of Applied Microbiology, RWTH Aachen University, Worringerweg 1, 52074 Aachen, Germany.
Lars RegesteinAVT‑Biochemical Engineering, RWTH Aachen University, Forckenbeckstr. 51, 52074 Aachen, Germany.
Miriam A RosenbaumInstitute of Applied Microbiology, RWTH Aachen University, Worringerweg 1, 52074 Aachen, Germany.
Jochen BüchsAVT‑Biochemical Engineering, RWTH Aachen University, Forckenbeckstr. 51, 52074 Aachen, Germany.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the biocatalytic conversion of cellulosic biomass could replace fossil oil for the production of various compounds, it is often not economically viable due to the high costs of cellulolytic enzymes. One possibility to reduce costs is consolidated bioprocessing (CBP), integrating cellulase production, hydrolysis of cellulose, and the fermentation of the released sugars to the desired product into one process step. To establish such a process, the most suitable cellulase-producing organism has to be identified. Thereby, it is crucial to evaluate the candidates under target process conditions. In this work, the chosen model process was the conversion of cellulose to the platform chemical itaconic acid by a mixed culture of a cellulolytic fungus with

resultsThe screening of five different cellulase producers with the freeze assay identified

conclusionsWith two complementary methods to quantify cellulase activity and the dynamics of cellulase production for CBP applications,

Indexed as

Cellulase activityCelluloseConsolidated bioprocessingFreeze assayItaconic acidPenicillium verruculosumRespiration activityTrichoderma reesei

Identifiers

PMID28450887
PMCPMC5402656
OpenAlexW2608089746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.